Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) GF Value : ¥10.73 (As of May. 27, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Guizhou Bailing Group Pharmaceutical Co GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-27), Guizhou Bailing Group Pharmaceutical Co's share price is ¥4.14. Guizhou Bailing Group Pharmaceutical Co's GF Value is ¥10.73. Therefore, Guizhou Bailing Group Pharmaceutical Co's Price-to-GF-Value for today is 0.39.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Guizhou Bailing Group Pharmaceutical Co is Possible Value Trap, Think Twice.

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Guizhou Bailing Group Pharmaceutical Co's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	4.14	/	10.73
	=	0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guizhou Bailing Group Pharmaceutical Co GF Value Related Terms

Thank you for viewing the detailed overview of Guizhou Bailing Group Pharmaceutical Co's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Bailing Group Pharmaceutical Co Ltd (SZSE:002424) » Definitions » GF Value

Traded in Other Exchanges

N/A

Address

Economic and Technological Development Zone, Air Boulevard West, Anshun City, CHN, 561000

Website

http://www.gzbl.com

Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company. It is engaged in the production and sale of medicinal tablets, capsules, and syrups.

Executives

Jiang Wei	Director
Jiang Yong	Directors, executives
Chen Pei	Directors, executives
Kuang Xun Hua	Director
Niu Min	Directors, Directors, and Executives
Chen Zhi	Securities Affairs Representative
Zheng Rong	Executives
Li Qiang	Supervisors
Xia Wen	Supervisors
Wang Xiao Dong	Supervisors
Teng Chun Jie	Supervisors
Li Hui Fang	Supervisors
Zhang Jin Fen	Director
Cai Shou Xian	Executives

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Headlines

No Headlines